{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "bad32605",
   "metadata": {},
   "source": [
    "# RAG Pipeline Exercise\n",
    "\n",
    "In this exercise you will build and **compare two simple Retrieval-Augmented Generation (RAG) pipelines**.\n",
    "\n",
    "You will work with a small collection of PDF documents (e.g. medical guidelines) and:\n",
    "\n",
    "1. Load and chunk the PDF documents.\n",
    "2. Create a vector index using **embedding model A** (local `BAAI/bge-m3`).\n",
    "3. Create a second index using **embedding model B** (e.g. OpenAI or Gemini embeddings).\n",
    "4. Implement a simple **retriever** and an **answering function** that calls an LLM with retrieved context.\n",
    "5. Automatically **generate questions** from the documents and use them to **compare two RAG configurations**.\n",
    "\n",
    "Cells marked with `# TODO` are **for students to implement**.\n",
    "Everything else is provided scaffolding."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4ddf82e6",
   "metadata": {},
   "source": [
    "## 0. Setup & Imports"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "be93ec53",
   "metadata": {},
   "outputs": [],
   "source": [
    "# TODO (easy): skim the imports and make sure you understand what each library is used for.\n",
    "\n",
    "from dotenv import load_dotenv  # Load environment variables from .env files\n",
    "import os  # Operating system interface (paths, env vars)\n",
    "os.environ[\"TF_USE_LEGACY_KERAS\"] = \"1\"\n",
    "import glob  # File pattern matching (finding files)\n",
    "from PyPDF2 import PdfReader  # Reading PDF files\n",
    "from langchain_text_splitters import RecursiveCharacterTextSplitter  # Splitting text into chunks for RAG\n",
    "from sentence_transformers import SentenceTransformer  # Generating text embeddings\n",
    "import faiss  # Efficient similarity search and clustering of dense vectors\n",
    "import pickle  # Serializing and deserializing Python objects\n",
    "import random  # Generating random numbers\n",
    "import numpy as np  # Numerical computing and array operations\n",
    "import pandas as pd  # Data manipulation and analysis\n",
    "\n",
    "# LLM / API clients (we will mainly use OpenAI here; Gemini can be added as a bonus)\n",
    "from openai import OpenAI  # OpenAI API client\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "68f16980",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load API keys from .env (you need to create this file once and add your keys)\n",
    "load_dotenv()\n",
    "\n",
    "deepinfra_key = os.getenv(\"DEEPINFRA_API_KEY\")\n",
    "openai_api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "google_api_key = os.getenv(\"GOOGLE_API_KEY\")\n",
    "anthropic_api_key = os.getenv(\"ANTHROPIC_API_KEY\")\n",
    "\n",
    "# For this exercise we mainly use OpenAI for both embeddings (RAG B) and chat completions.\n",
    "assert openai_api_key is not None, \"Please set OPENAI_API_KEY in your .env file.\"\n",
    "openai_client = OpenAI(api_key=openai_api_key)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "23ebcf52",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Make pandas show the full table and full cell content\n",
    "pd.set_option(\"display.max_rows\", None)       # show all rows\n",
    "pd.set_option(\"display.max_columns\", None)    # show all columns\n",
    "pd.set_option(\"display.max_colwidth\", None)   # don't truncate cell text"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fba2719d",
   "metadata": {},
   "source": [
    "## 1. Load PDF documents\n",
    "\n",
    "We assume there is a `data/` folder containing one or more PDF files.\n",
    "\n",
    "**Task:** implement `load_pdfs(glob_path)` so that it:\n",
    "- Iterates over all PDF files matching `glob_path`\n",
    "- Reads them with `PdfReader`\n",
    "- Concatenates the text of all pages into **one long string**."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "d8abcb21",
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_pdfs(glob_path: str = \"data/*.pdf\") -> str:\n",
    "    \"\"\"Load all PDFs matching the pattern and return their combined text.\n",
    "\n",
    "    TODO:\n",
    "    - Use `glob.glob(glob_path)` to iterate over file paths\n",
    "    - For each file, open it in binary mode and create a `PdfReader`\n",
    "    - Loop over `reader.pages` and extract text with the extract_text() function\n",
    "    - Concatenate everything into a single string `text`\n",
    "    - Be robust: skip pages where `extract_text()` returns None\n",
    "    \"\"\"\n",
    "    # YOUR CODE HERE\n",
    "    text = \"\"\n",
    "    for pdf_path in glob.glob(glob_path):\n",
    "        with open(pdf_path, \"rb\") as f:\n",
    "            reader = PdfReader(f)\n",
    "            for page in reader.pages:\n",
    "                page_text = page.extract_text()\n",
    "                if page_text:\n",
    "                    text += \" \" + page_text\n",
    "    return text\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "416c3ad0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of characters: 230708\n",
      "Preview:  Asthma: diagnosis, \n",
      "moni toring and chr onic \n",
      "asthma manag emen t (BTS, \n",
      "NICE, SI GN) \n",
      "NICE guideline \n",
      "Published: 27 No vember 202 4 \n",
      "www .nice.or g.uk/guidance/ng2 45 \n",
      "© NICE 202 4. All right s reserved. Subject t o Notice of right s (https://www .nice.or g.uk/t erms-and-\n",
      "conditions#notice-of -right s). Your r esponsi bility \n",
      "The r ecommendations in t his guideline r epresent t he view of NICE, arriv ed at aft er car eful \n",
      "consideration of t he evidence a vailable. When e xercising t heir judg\n"
     ]
    }
   ],
   "source": [
    "# Run once and inspect\n",
    "raw_text = load_pdfs(\"data/*.pdf\")\n",
    "print(\"Number of characters:\", len(raw_text))\n",
    "print(\"Preview:\", raw_text[:500])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5c0c5a14",
   "metadata": {},
   "source": [
    "## 2. Chunk the text\n",
    "\n",
    "We will split the long text into overlapping chunks.\n",
    "\n",
    "Later you can **experiment** with different `chunk_size` and `chunk_overlap` to see how it affects retrieval.\n",
    "\n",
    "**Task:** start with the given parameters, run once, then try at least one alternative configuration and note the effects."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "a4e3f802",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RAG A: 130 chunks produced, first chunk length = 1995\n",
      "RAG B: 260 chunks produced, first chunk length = 979\n"
     ]
    }
   ],
   "source": [
    "# Base configuration (RAG A)\n",
    "chunk_size_a = 2000  # Bigger chunks: captures more context and narrative flow, fewer total chunks\n",
    "chunk_overlap_a = 200  # Overlap: ensures continuity across boundaries so context isn't lost\n",
    "\n",
    "splitter_a = RecursiveCharacterTextSplitter(\n",
    "    chunk_size=chunk_size_a,\n",
    "    chunk_overlap=chunk_overlap_a\n",
    ")\n",
    "\n",
    "chunks_a = splitter_a.split_text(raw_text)\n",
    "print(f\"RAG A: {len(chunks_a)} chunks produced, first chunk length = {len(chunks_a[0])}\")\n",
    "\n",
    "# TODO (mini-experiment): change chunk_size / chunk_overlap for RAG B and compare\n",
    "chunk_size_b = 1000   # Smaller chunks: more granular/precise retrieval, more chunks, but might miss broader context\n",
    "chunk_overlap_b = 100\n",
    "\n",
    "splitter_b = RecursiveCharacterTextSplitter(\n",
    "    chunk_size=chunk_size_b,\n",
    "    chunk_overlap=chunk_overlap_b\n",
    ")\n",
    "\n",
    "chunks_b = splitter_b.split_text(raw_text)\n",
    "print(f\"RAG B: {len(chunks_b)} chunks produced, first chunk length = {len(chunks_b[0])}\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ec3511f4",
   "metadata": {},
   "source": [
    "## 3. Create embeddings and a FAISS index\n",
    "\n",
    "We start with **Embedding model A: `BAAI/bge-small-en`** using `sentence-transformers`.\n",
    "\n",
    "Then, as an optional extension, you can build **Embedding model B** using OpenAI or Gemini and compare.\n",
    "\n",
    "To keep the exercise manageable, the base version only **requires** BGE."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "b519161f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Embedding dimensionality (A): 384\n",
      "FAISS index (A) size: 130\n"
     ]
    }
   ],
   "source": [
    "# Embedding model A (local)\n",
    "model_name_a = \"BAAI/bge-small-en\"  # Specify the pre-trained model (small and efficient for English)\n",
    "embedder_a = SentenceTransformer(model_name_a)  # Load the model into memory\n",
    "\n",
    "# Compute embeddings for all chunks of configuration A\n",
    "# This converts text chunks into numerical vectors (embeddings)\n",
    "embeddings_a = embedder_a.encode(chunks_a, convert_to_numpy=True)\n",
    "\n",
    "dimensions_a = embeddings_a.shape[1]  # Get vector size (e.g., 384 dimensions) required for FAISS\n",
    "print(\"Embedding dimensionality (A):\", dimensions_a)\n",
    "\n",
    "index_a = faiss.IndexFlatL2(dimensions_a)  # Create a FAISS index using L2 (Euclidean) distance\n",
    "index_a.add(embeddings_a)  # Add the calculated embeddings to the index for searching\n",
    "print(\"FAISS index (A) size:\", index_a.ntotal)\n",
    "\n",
    "# Persist index/chunks if you like (optional)\n",
    "os.makedirs(\"faiss\", exist_ok=True)  # Create directory if it doesn't exist\n",
    "faiss.write_index(index_a, \"faiss/faiss_index_a.index\")  # Save the vector index to disk\n",
    "with open(\"faiss/chunks_a.pkl\", \"wb\") as f:\n",
    "    pickle.dump(chunks_a, f)  # Save the original text chunks (FAISS only stores vectors, not text)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "77271916",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "FAISS index (B) size: 260\n"
     ]
    }
   ],
   "source": [
    "# Embedding model B using OpenAI embeddings.\n",
    "\n",
    "# TODO:\n",
    "# - Use `openai_client.embeddings.create(...)` to compute embeddings for `chunks_b`\n",
    "# - Create a second FAISS index `index_b`\n",
    "# - Make sure to check the dimensionality from the first embedding vector\n",
    "\n",
    "# Example sketch (not complete, adapt & run if you have API access):\n",
    "# Initialize OpenAI client\n",
    "openai_client = OpenAI(api_key=openai_api_key)  # Sets up the client to communicate with OpenAI API\n",
    "\n",
    "# TODO fulfilled: Use `openai_client.embeddings.create(...)` to compute embeddings\n",
    "response = openai_client.embeddings.create(\n",
    "     model=\"text-embedding-3-small\",  # Specifies the model (1536 dimensions for this specific model)\n",
    "    input=chunks_b  # Sends the list of text chunks to be converted into vectors\n",
    ")\n",
    "\n",
    "# Extract the actual embedding vectors from the API response object into a numpy array\n",
    "embeddings_b = np.array([item.embedding for item in response.data])\n",
    "\n",
    "# TODO fulfilled: Check dimensionality (crucial because FAISS needs the exact vector size)\n",
    "dim_b = embeddings_b.shape[1]  # dynamically gets the dimension (e.g., 1536) from the first vector\n",
    "\n",
    "# TODO fulfilled: Create a second FAISS index `index_b`\n",
    "index_b = faiss.IndexFlatL2(dim_b)  # Initializes a new index structure for the OpenAI embeddings\n",
    "\n",
    "index_b.add(embeddings_b)  # Populates the index with the vectors so they can be searched\n",
    "print(\"FAISS index (B) size:\", index_b.ntotal)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0339224e",
   "metadata": {},
   "source": [
    "## 4. Implement a simple retriever\n",
    "\n",
    "We now implement a generic retrieval function that:\n",
    "1. Embeds the query.\n",
    "2. Searches the FAISS index.\n",
    "3. Returns the corresponding text chunks.\n",
    "\n",
    "We implement it for configuration A. If you built configuration B, you can reuse the same function."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "aa6fbf82",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of retrieved chunks: 3\n",
      "Preview of first chunk: and signs of ot her causes of r espirat ory sympt oms but be awar e that e ven if \n",
      "examination r esult s are normal, t he person ma y still ha ve ast hma. [NICE 2017] \n",
      "Initial tr eatmen t and obje ctive tests f or acu te sym ptoms a t \n",
      "presen tation \n",
      "1.1.5 Treat people immediat ely if t hey are acut ely unw ell or highly sympt omatic at \n",
      "presentation, and per form objectiv e tests that ma y help s\n"
     ]
    }
   ],
   "source": [
    "def retrieve_texts(query: str, k: int, index, chunks, embedder) -> list:\n",
    "    \"\"\"Return the top-k most similar chunks for a query.\n",
    "\n",
    "    TODO (students):\n",
    "    - Encode the query with `embedder.encode(...)`\n",
    "    - Call `index.search(query_embedding, k)`\n",
    "    - Use the returned indices to select the chunks\n",
    "    - Return a list of strings (chunks)\n",
    "    \"\"\"\n",
    "    # YOUR CODE HERE\n",
    "    # TODO fulfilled: Encode the query. Wrapped in [query] because the model expects a batch; converted to numpy for FAISS.\n",
    "    query_emb = embedder.encode([query], convert_to_numpy=True)\n",
    "    \n",
    "    # TODO fulfilled: Search the index. Finds the top 'k' closest vectors; returns distances and their integer indices.\n",
    "    distances, indices = index.search(query_emb, k)\n",
    "    \n",
    "    # TODO fulfilled: Use returned indices to select chunks. indices[0] contains the results for our single query.\n",
    "    retrieved = [chunks[i] for i in indices[0]]\n",
    "    \n",
    "    # TODO fulfilled: Return the list of strings (chunks).\n",
    "    return retrieved\n",
    "\n",
    "# Quick sanity check\n",
    "test_query = \"What is the most important factor in diagnosing asthma?\"\n",
    "retrieved_text = retrieve_texts(test_query, k=3, index=index_a, chunks=chunks_a, embedder=embedder_a)\n",
    "print(\"Number of retrieved chunks:\", len(retrieved_text))\n",
    "print(\"Preview of first chunk:\", retrieved_text[0][:400])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "84287470",
   "metadata": {},
   "outputs": [],
   "source": [
    "def openai_embed_query(query: str) -> np.ndarray:\n",
    "    \"\"\"\n",
    "    Compute an OpenAI embedding for a single query string and\n",
    "    return it as a NumPy array of shape (1, dim).\n",
    "    \"\"\"\n",
    "    resp = openai_client.embeddings.create(\n",
    "        model=\"text-embedding-3-small\",\n",
    "        input=[query]  # list with one string\n",
    "    )\n",
    "    vec = np.array(resp.data[0].embedding, dtype=\"float32\")\n",
    "    return vec.reshape(1, -1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "68ab8b40",
   "metadata": {},
   "outputs": [],
   "source": [
    "def retrieve_texts_b(query: str, k: int, index, chunks) -> list:\n",
    "    \"\"\"\n",
    "    Retrieve top-k chunks using OpenAI embeddings for the query.\n",
    "    \"\"\"\n",
    "    query_emb = openai_embed_query(query)  # shape (1, dim)\n",
    "    distances, indices = index.search(query_emb, k)\n",
    "    retrieved = [chunks[i] for i in indices[0]]\n",
    "    return retrieved"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f646fdc6",
   "metadata": {},
   "source": [
    "## 5. Implement `answer_query` using an LLM\n",
    "\n",
    "Now we build the actual RAG call:\n",
    "\n",
    "1. Use `retrieve_texts` to get top-`k` chunks.\n",
    "2. Concatenate them into a context string.\n",
    "3. Build a prompt that:\n",
    "   - shows the context\n",
    "   - asks the model to answer the user question based **only** on this context.\n",
    "4. Call the OpenAI chat completion API.\n",
    "\n",
    "This is the **core RAG function**."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "0d94610c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RAG answer: The most important factor in diagnosing asthma is the history suggesting asthma combined with objective tests that may support a diagnosis, such as eosinophil count, fractional exhaled nitric oxide (FeNO), spirometry, and peak expiratory flow (PEF).\n"
     ]
    }
   ],
   "source": [
    "def answer_query_a(query: str, k: int, index, chunks, embedder, client: OpenAI) -> str:\n",
    "    \"\"\"RAG-style answer: retrieve context and ask an LLM.\n",
    "\n",
    "    TODO (students):\n",
    "    - Use `retrieve_texts` to get `k` relevant chunks.\n",
    "    - Join them into a single context string.\n",
    "    - Build a chat prompt that instructs the model to answer *only* using the context.\n",
    "    - Call `client.chat.completions.create(...)` with model `\"gpt-4o-mini\"` (or similar).\n",
    "    - Return the model's answer text.\n",
    "    \"\"\"\n",
    "    # TODO fulfilled: Use `retrieve_texts` to get `k` relevant chunks.\n",
    "    retrieved_chunks = retrieve_texts(query, k, index, chunks, embedder)\n",
    "    \n",
    "    # TODO fulfilled: Join them into a single context string. \n",
    "    # We use a separator (\"\\n\\n---\\n\\n\") to clearly distinguish between different source chunks.\n",
    "    context = \"\\n\\n---\\n\\n\".join(retrieved_chunks)\n",
    "\n",
    "    # TODO fulfilled: Build a chat prompt that instructs the model to answer *only* using the context.\n",
    "    system_prompt = (\n",
    "        \"You are a helpful assistant answering questions based ONLY on the provided context. \"\n",
    "        \"If the answer is not in the context, say that you do not know.\"\n",
    "    )\n",
    "\n",
    "    # Structure the conversation history for the API (System instruction + User query with context)\n",
    "    messages = [\n",
    "        {\"role\": \"system\", \"content\": system_prompt},\n",
    "        {\"role\": \"user\", \"content\": f\"Context:\\n{context}\\n\\nQuestion: {query}\"}\n",
    "    ]\n",
    "\n",
    "    # TODO fulfilled: Call `client.chat.completions.create(...)` with model `\"gpt-4o-mini\"`.\n",
    "    completion = client.chat.completions.create(\n",
    "        model=\"gpt-4o-mini\",\n",
    "        messages=messages\n",
    "    )\n",
    "\n",
    "    # TODO fulfilled: Return the model's answer text.\n",
    "    # We access choices[0] because we only requested one completion (n=1 by default).\n",
    "    return completion.choices[0].message.content.strip()\n",
    "\n",
    "# Quick manual test\n",
    "answer = answer_query_a(test_query, k=3, index=index_a, chunks=chunks_a, embedder=embedder_a, client=openai_client)\n",
    "print(\"RAG answer:\", answer)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4b13aade",
   "metadata": {},
   "source": [
    "### Answer Function with the other embedding type"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "5994c414",
   "metadata": {},
   "outputs": [],
   "source": [
    "def answer_query_b(query: str, k: int, index, chunks, client: OpenAI) -> str:\n",
    "    \"\"\"\n",
    "    RAG-style answer for configuration B (OpenAI embeddings + chunking B).\n",
    "    \"\"\"\n",
    "    # Retrieve relevant chunks using the OpenAI-specific retrieval function\n",
    "    # We pass 'client' here so the function can call the OpenAI embedding API\n",
    "    retrieved_chunks = retrieve_texts_b(query, k, index, chunks)\n",
    "    \n",
    "    # Join the retrieved chunks into a single context string\n",
    "    # The separator \"\\n\\n---\\n\\n\" helps the LLM distinguish between different text sources\n",
    "    context = \"\\n\\n---\\n\\n\".join(retrieved_chunks)\n",
    "\n",
    "    # Define the system prompt to enforce strict context usage (Grounding)\n",
    "    system_prompt = (\n",
    "        \"You are a helpful assistant answering questions based ONLY on the provided context. \"\n",
    "        \"If the answer is not in the context, say that you do not know.\"\n",
    "    )\n",
    "\n",
    "    # Construct the message history: System instructions + User query with injected context\n",
    "    messages = [\n",
    "        {\"role\": \"system\", \"content\": system_prompt},\n",
    "        {\"role\": \"user\", \"content\": f\"Context:\\n{context}\\n\\nQuestion: {query}\"},\n",
    "    ]\n",
    "\n",
    "    # Call the LLM (GPT-4o-mini) to generate the final answer\n",
    "    completion = client.chat.completions.create(\n",
    "        model=\"gpt-4o-mini\",\n",
    "        messages=messages,\n",
    "    )\n",
    "\n",
    "    # Extract and return the text content from the model's response\n",
    "    return completion.choices[0].message.content.strip()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7a86a92e",
   "metadata": {},
   "source": [
    "## 6. Generate questions from random chunks (automatic evaluation set)\n",
    "\n",
    "To compare two RAG configurations, we need **questions**.\n",
    "\n",
    "We will:\n",
    "- randomly sample a few chunks from the corpus,\n",
    "- ask an LLM to generate a **good question** whose answer is contained in the chunk.\n",
    "\n",
    "Then we can use these question–chunk pairs as a small evaluation set.\n",
    "\n",
    "We provide most of the implementation. Your job is mainly to:\n",
    "- inspect the code,\n",
    "- understand the prompt,\n",
    "- maybe tweak the number of chunks or retries."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "eb899fb6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Q1: What factors influenced the committee's decision to retain and update the step 4 treatment recommendations for hypertension, despite a lack of new evidence?\n",
      "  From chunk preview: developed t o suppor t healt hcare professionals and people wit h hyper tension t o discuss \n",
      "their tr eatment options an...\n",
      "\n",
      "Q2: What are the recommended strategies for monitoring asthma control during patient reviews, according to the guidelines from NICE and BTS/SIGN?\n",
      "  From chunk preview: specialist. [NICE 2017] \n",
      "1.5 M onitoring asthma c ontrol \n",
      "1.5.1 Monit or asthma contr ol at every review . In addition t...\n",
      "\n",
      "Q3: What steps should be taken if a child under 5 with suspected asthma continues to experience symptoms despite a trial of low-dose inhaled corticosteroids and short-acting beta-2 agonists?\n",
      "  From chunk preview: childr en under 5 . \n",
      "1.9.1 Consider an 8 t o12 w eek trial of twice-daily paediatric lo w-dose inhaled \n",
      "corticost eroid ...\n",
      "\n",
      "Q4: What evidence led the committee to recommend low-dose inhaled corticosteroids (ICS) as the preferred treatment for children aged 5 to 11, and how might this shift in recommendations impact current asthma management practices?\n",
      "  From chunk preview: applies her e. The r ecommendations ar e not based on a specific e vidence sear ch, but t he \n",
      "committ ee not ed that peo...\n",
      "\n",
      "Q5: What are the recommended immediate steps and objective tests for diagnosing asthma in individuals who present with acute respiratory symptoms?\n",
      "  From chunk preview: and signs of ot her causes of r espirat ory sympt oms but be awar e that e ven if \n",
      "examination r esult s are normal, t h...\n",
      "\n"
     ]
    }
   ],
   "source": [
    "def generate_questions_for_random_chunks(chunks, num_chunks: int = 5, max_retries: int = 2):\n",
    "    # TODO (tweak): Change 'num_chunks' here if you want a larger evaluation set (e.g., 10 or 20)\n",
    "    selected_chunks = random.sample(chunks, num_chunks) # Randomly select a subset of chunks to test on\n",
    "    qa_pairs = []\n",
    "\n",
    "    for chunk in selected_chunks:\n",
    "        # TODO (inspect): This prompt instructs the LLM to create a question based on the text.\n",
    "        # You could modify this to ask for \"hard\" questions, \"true/false\" questions, etc.\n",
    "        prompt = (\n",
    "            \"Based on the following text, generate an insightful question that covers its key content:\\n\\n\"\n",
    "            \"Text:\\n\" + chunk + \"\\n\\n\"\n",
    "            \"Question:\"\n",
    "        )\n",
    "\n",
    "        question = None\n",
    "        # Retry loop: handles occasional API errors or timeouts\n",
    "        for attempt in range(max_retries):\n",
    "            try:\n",
    "                # Ask the LLM to generate the question\n",
    "                completion = openai_client.chat.completions.create(\n",
    "                    model=\"gpt-4o-mini\",\n",
    "                    messages=[{\"role\": \"user\", \"content\": prompt}]\n",
    "                )\n",
    "                question = completion.choices[0].message.content.strip()\n",
    "                if question:\n",
    "                    break # Successfully generated a question, stop retrying\n",
    "            except Exception as e:\n",
    "                print(\"Error while generating question, retrying...\", e)\n",
    "\n",
    "        if question is None:\n",
    "            question = \"Error: could not generate question.\"\n",
    "\n",
    "        # Save the pair: (The original text chunk, The generated question)\n",
    "        # This creates our \"Ground Truth\" for evaluation later\n",
    "        qa_pairs.append((chunk, question))\n",
    "\n",
    "    return qa_pairs\n",
    "\n",
    "# Execute the function\n",
    "# TODO: You can increase num_chunks here to generate a bigger test set\n",
    "questions = generate_questions_for_random_chunks(chunks_a, num_chunks=5, max_retries=2)\n",
    "\n",
    "for i, (chunk, q) in enumerate(questions, 1):\n",
    "    print(f\"Q{i}: {q}\\n  From chunk preview: {chunk[:120]}...\\n\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3fd0eaf5",
   "metadata": {},
   "source": [
    "## 7. Compare two RAG configurations\n",
    "\n",
    "Now we can:\n",
    "- Use the generated questions,\n",
    "- Answer them with RAG configuration A (BGE + chunking A),\n",
    "- (Optional) Answer them with RAG configuration B (e.g. different chunking and/or different embeddings),\n",
    "- Compare the answers qualitatively.\n",
    "\n",
    "To keep the exercise manageable, we start with config A only.\n",
    "If you implemented config B, reuse `answer_query` with `index_b`, `chunks_b`, and your second embedder."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "a292474a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Question: What factors influenced the committee's decision to retain and update the step 4 treatment recommendations for hypertension, despite a lack of new evidence?\n",
      "Answer A: The committee's decision to retain and update the step 4 treatment recommendations for hypertension was influenced by their significant clinical experience with the safe and effective use of alpha- or beta-blockers. They agreed that adding another drug is likely to have a greater effect on blood pressure than increasing the thiazide diuretic dose, which was supported by their discussion surrounding the lack of evidence for high-dose thiazide diuretics improving cardiovascular outcomes. Additionally, they considered the need for clarity regarding the features that warrant same-day referral and the importance of quickly investigating target organ damage before treatment decisions for those with severely raised blood pressure but no other concerning symptoms.\n",
      "Source chunk preview: developed t o suppor t healt hcare professionals and people wit h hyper tension t o discuss \n",
      "their tr eatment options and mak e informed decisions. \n",
      "H ...\n",
      "------------------------------------------------------------\n",
      "Question: What are the recommended strategies for monitoring asthma control during patient reviews, according to the guidelines from NICE and BTS/SIGN?\n",
      "Answer A: The guidelines do not specify the recommended strategies for monitoring asthma control during patient reviews. Therefore, I do not know the answer to your question.\n",
      "Source chunk preview: specialist. [NICE 2017] \n",
      "1.5 M onitoring asthma c ontrol \n",
      "1.5.1 Monit or asthma contr ol at every review . In addition t o asking about sympt oms, \n",
      "ch ...\n",
      "------------------------------------------------------------\n",
      "Question: What steps should be taken if a child under 5 with suspected asthma continues to experience symptoms despite a trial of low-dose inhaled corticosteroids and short-acting beta-2 agonists?\n",
      "Answer A: If a child under 5 with suspected asthma continues to experience symptoms despite a trial of low-dose inhaled corticosteroids (ICS) and short-acting beta-2 agonists (SABA), the following sequential steps should be taken:\n",
      "\n",
      "1. Check inhaler technique and adherence.\n",
      "2. Check whether there is an environmental source of their symptoms (e.g., mould in the home, cold housing, smokers, or indoor air pollution).\n",
      "3. Review whether an alternative diagnosis is likely.\n",
      "\n",
      "If none of these explain the failure to respond to treatment, the child should be referred to a specialist in asthma care.\n",
      "Source chunk preview: childr en under 5 . \n",
      "1.9.1 Consider an 8 t o12 w eek trial of twice-daily paediatric lo w-dose inhaled \n",
      "corticost eroid (ICS) as maint enance t herap  ...\n",
      "------------------------------------------------------------\n",
      "Question: What evidence led the committee to recommend low-dose inhaled corticosteroids (ICS) as the preferred treatment for children aged 5 to 11, and how might this shift in recommendations impact current asthma management practices?\n",
      "Answer A: The committee recommended regular low-dose inhaled corticosteroids (ICS) plus a short-acting beta 2 agonist (SABA) as the initial treatment for children aged 5 to 11 with newly diagnosed asthma based on several studies that addressed the question of optimal therapy. This evidence indicated that low-dose ICS alongside SABA was effective for managing asthma in this age group.\n",
      "\n",
      "Additionally, a single study demonstrated that maintenance and reliever therapy (MART) was superior to both regular moderate-dose ICS plus SABA as needed and regular low-dose ICS/long-acting beta agonist (LABA) plus SABA as needed. MART not only reduced the number of exacerbations and the need for a reliever inhaler but also resulted in fewer adverse events.\n",
      "\n",
      "The economic analysis associated with this guideline update suggested that the MART regimen was linked to lower costs and resulted in more quality-adjusted life years (QALYs) compared to the other treatment strategies.\n",
      "\n",
      "The shift in recommendations may align current management practices more closely with evidence-based approaches, ensuring that children with asthma receive more effective treatment tailored to their needs, potentially leading to better control of symptoms and fewer exacerbations.\n",
      "Source chunk preview: applies her e. The r ecommendations ar e not based on a specific e vidence sear ch, but t he \n",
      "committ ee not ed that people in t he MART studies r evi ...\n",
      "------------------------------------------------------------\n",
      "Question: What are the recommended immediate steps and objective tests for diagnosing asthma in individuals who present with acute respiratory symptoms?\n",
      "Answer A: The recommended immediate steps and objective tests for diagnosing asthma in individuals who present with acute respiratory symptoms are as follows:\n",
      "\n",
      "1. Treat people immediately if they are acutely unwell or highly symptomatic at presentation.\n",
      "2. Perform objective tests that may help support a diagnosis of asthma, such as:\n",
      "   - Eosinophil count\n",
      "   - Fractional exhaled nitric oxide (FeNO)\n",
      "   - Spirometry\n",
      "   - Peak expiratory flow (PEF) before and after bronchodilator, if the equipment is available.\n",
      "3. If objective tests for asthma cannot be done immediately, carry them out when acute symptoms have been controlled and advise people to contact their healthcare professional if they become unwell while waiting for the tests. \n",
      "\n",
      "These steps ensure timely intervention and accurate diagnosis in acute situations.\n",
      "Source chunk preview: and signs of ot her causes of r espirat ory sympt oms but be awar e that e ven if \n",
      "examination r esult s are normal, t he person ma y still ha ve ast  ...\n",
      "------------------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "def answer_generated_questions_a(question_tuples, k, index, chunks, embedder, client):\n",
    "    \"\"\"\n",
    "    Runs the RAG pipeline (Config A) on a list of (chunk, question) pairs to evaluate performance.\n",
    "    \"\"\"\n",
    "    results = []\n",
    "    # Iterate through the evaluation set (ground truth chunk + generated question) created in Step 6\n",
    "    for chunk, question in question_tuples:\n",
    "        # Generate an answer using RAG Configuration A\n",
    "        answer = answer_query_a(question, k, index, chunks, embedder, client)\n",
    "        \n",
    "        # Store the triplet: Source Text (Truth), Question, and RAG Answer for comparison\n",
    "        results.append({\n",
    "            \"chunk\": chunk,\n",
    "            \"question\": question,\n",
    "            \"answer\": answer\n",
    "        })\n",
    "    return results\n",
    "\n",
    "# Execute the evaluation for Configuration A\n",
    "results_a = answer_generated_questions_a(\n",
    "    questions,          # The list of generated questions from Step 6\n",
    "    k=5,                # Retrieve top 5 chunks for context\n",
    "    index=index_a,      # Use FAISS index A\n",
    "    chunks=chunks_a,    # Use Text Chunks A\n",
    "    embedder=embedder_a,# Use Local Embedder (BGE)\n",
    "    client=openai_client,\n",
    ")\n",
    "\n",
    "# Print the results for manual qualitative inspection\n",
    "for item in results_a:\n",
    "    print(\"Question:\", item[\"question\"])\n",
    "    print(\"Answer A:\", item[\"answer\"])\n",
    "    # Show a snippet of the original chunk to see if the answer aligns with the source truth\n",
    "    print(\"Source chunk preview:\", item[\"chunk\"][:150], \"...\")\n",
    "    print(\"-\" * 60)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2ec212b7",
   "metadata": {},
   "source": [
    "### Extension: add RAG B and create a comparison table\n",
    "\n",
    "If you implemented a second configuration (e.g. different chunking + OpenAI embeddings):\n",
    "\n",
    "1. Build `index_b` using OpenAI embeddings and `chunks_b`.\n",
    "2. Implement `openai_embed_query`, `retrieve_texts_b`, and `answer_query_b`.\n",
    "3. Run `results_b = answer_generated_questions_b(questions, k=5, index=index_b, chunks=chunks_b, client=openai_client)`.\n",
    "4. For each question, compare:\n",
    "   - Which answer is more complete / specific?\n",
    "   - Which one is better grounded in the source chunk?\n",
    "5. Summarise your findings in a short **markdown cell** or a small table.\n",
    "\n",
    "---\n",
    "\n",
    "This concludes the core RAG exercise.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "faa74961",
   "metadata": {},
   "outputs": [],
   "source": [
    "def answer_generated_questions_b(question_tuples, k, index, chunks, client):\n",
    "    \"\"\"\n",
    "    Use RAG B to answer a list of (chunk, question) pairs.\n",
    "    \"\"\"\n",
    "    results = []\n",
    "    # Loop through the validation set (ground truth chunk + question)\n",
    "    for chunk, question in question_tuples:\n",
    "        # Generate answer using the RAG B pipeline (OpenAI embeddings)\n",
    "        answer = answer_query_b(question, k, index, chunks, client)\n",
    "        results.append({\n",
    "            \"chunk\": chunk,\n",
    "            \"question\": question,\n",
    "            \"answer\": answer,\n",
    "        })\n",
    "    return results\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "e9ee1310",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Run the evaluation for Configuration B\n",
    "results_b = answer_generated_questions_b(\n",
    "    questions,          # Use the exact same questions as RAG A for fair comparison\n",
    "    k=5,                # Number of context chunks to retrieve\n",
    "    index=index_b,      # The FAISS index built with OpenAI embeddings\n",
    "    chunks=chunks_b,    # The text chunks corresponding to Config B (e.g., smaller chunks)\n",
    "    client=openai_client\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "bc18c46e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Question</th>\n",
       "      <th>Answer A (BGE + config A)</th>\n",
       "      <th>Answer B (OpenAI + config B)</th>\n",
       "      <th>Source chunk (A) preview</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>What factors influenced the committee's decision to retain and update the step 4 treatment recommendations for hypertension, despite a lack of new evidence?</td>\n",
       "      <td>The committee's decision to retain and update the step 4 treatment recommendations for hypertension was influenced by their significant clinical experience with the safe and effective use of alpha- or beta-blockers. They agreed that adding another drug is likely to have a greater effect on blood pressure than increasing the thiazide diuretic dose, which was supported by their discussion surrounding the lack of evidence for high-dose thiazide diuretics improving cardiovascular outcomes. Additionally, they considered the need for clarity regarding the features that warrant same-day referral and the importance of quickly investigating target organ damage before treatment decisions for those with severely raised blood pressure but no other concerning symptoms.</td>\n",
       "      <td>The committee's decision to retain and update the step 4 treatment recommendations for hypertension was influenced by several factors:\\n\\n1. **Clinical Experience**: The committee discussed their clinical experience and deemed it important in the absence of new evidence. \\n\\n2. **Previous Recommendations**: They considered the previous recommendations from the 2011 guideline, which were based on robust clinical and cost-effectiveness evidence.\\n\\n3. **Common Clinical Practice**: The use of aldosterone antagonists has become common in clinical practice, warranting the retention of related recommendations despite the lack of robust new evidence.\\n\\n4. **Ineffectiveness of Higher Doses**: The committee noted that studies had shown no improvement in cardiovascular outcomes at higher doses of thiazide diuretics in patients without resistant hypertension, influencing their perspective on step 4 treatment.\\n\\n5. **Clinical Safety**: The committee found significant clinical experience supporting the safe and effective use of alpha- or beta-blockers, reinforcing the decision to retain related recommendations.\\n\\nOverall, the combination of established clinical practice, expert consensus, and safety considerations contributed to the decision to retain and update the recommendations for step 4 treatment.</td>\n",
       "      <td>developed t o suppor t healt hcare professionals and people wit h hyper tension t o discuss \\ntheir tr eatment options and mak e informed decisions. \\nHow the r ecommenda tions mig ht affect practice \\nT...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>What are the recommended strategies for monitoring asthma control during patient reviews, according to the guidelines from NICE and BTS/SIGN?</td>\n",
       "      <td>The guidelines do not specify the recommended strategies for monitoring asthma control during patient reviews. Therefore, I do not know the answer to your question.</td>\n",
       "      <td>The recommended strategies for monitoring asthma control during patient reviews according to the guidelines from NICE and BTS/SIGN include:\\n\\n1. Use of a validated symptom questionnaire (e.g., the Asthma Control Questionnaire, the Asthma Control Test, or the Childhood Asthma Control Test) at any asthma review.\\n2. Monitoring the amount of reliever inhaler used, including a check of the prescription record.\\n3. Keeping track of the number of courses of oral corticosteroids.\\n4. Documenting any admissions to hospital or attendance at an emergency department due to asthma.\\n5. Considering fractional exhaled nitric oxide (FeNO) monitoring for adults with asthma at their regular review. \\n\\nAdditionally, if asthma control is deemed suboptimal, the recommendations suggest referring to the principles of pharmacological treatment.</td>\n",
       "      <td>specialist. [NICE 2017] \\n1.5 M onitoring asthma c ontrol \\n1.5.1 Monit or asthma contr ol at every review . In addition t o asking about sympt oms, \\ncheck: \\n• time off w ork or school due t o ast hma \\n...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>What steps should be taken if a child under 5 with suspected asthma continues to experience symptoms despite a trial of low-dose inhaled corticosteroids and short-acting beta-2 agonists?</td>\n",
       "      <td>If a child under 5 with suspected asthma continues to experience symptoms despite a trial of low-dose inhaled corticosteroids (ICS) and short-acting beta-2 agonists (SABA), the following sequential steps should be taken:\\n\\n1. Check inhaler technique and adherence.\\n2. Check whether there is an environmental source of their symptoms (e.g., mould in the home, cold housing, smokers, or indoor air pollution).\\n3. Review whether an alternative diagnosis is likely.\\n\\nIf none of these explain the failure to respond to treatment, the child should be referred to a specialist in asthma care.</td>\n",
       "      <td>If a child under 5 with suspected asthma continues to experience symptoms despite a trial of low-dose inhaled corticosteroids (ICS) and short-acting beta-2 agonists (SABA), the following steps should be taken:\\n\\n1. Check inhaler technique and adherence.\\n2. Check whether there is an environmental source of their symptoms (for example, mould in the home, cold housing, smokers, or indoor air pollution).\\n3. Review whether an alternative diagnosis is likely.\\n\\nIf none of these explain the failure to respond to treatment, refer the child to a specialist in asthma care.</td>\n",
       "      <td>childr en under 5 . \\n1.9.1 Consider an 8 t o12 w eek trial of twice-daily paediatric lo w-dose inhaled \\ncorticost eroid (ICS) as maint enance t herap y (wit h a shor t-acting beta 2 agonist \\n[SABA] f ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>What evidence led the committee to recommend low-dose inhaled corticosteroids (ICS) as the preferred treatment for children aged 5 to 11, and how might this shift in recommendations impact current asthma management practices?</td>\n",
       "      <td>The committee recommended regular low-dose inhaled corticosteroids (ICS) plus a short-acting beta 2 agonist (SABA) as the initial treatment for children aged 5 to 11 with newly diagnosed asthma based on several studies that addressed the question of optimal therapy. This evidence indicated that low-dose ICS alongside SABA was effective for managing asthma in this age group.\\n\\nAdditionally, a single study demonstrated that maintenance and reliever therapy (MART) was superior to both regular moderate-dose ICS plus SABA as needed and regular low-dose ICS/long-acting beta agonist (LABA) plus SABA as needed. MART not only reduced the number of exacerbations and the need for a reliever inhaler but also resulted in fewer adverse events.\\n\\nThe economic analysis associated with this guideline update suggested that the MART regimen was linked to lower costs and resulted in more quality-adjusted life years (QALYs) compared to the other treatment strategies.\\n\\nThe shift in recommendations may align current management practices more closely with evidence-based approaches, ensuring that children with asthma receive more effective treatment tailored to their needs, potentially leading to better control of symptoms and fewer exacerbations.</td>\n",
       "      <td>The committee recommended regular paediatric low-dose ICS plus SABA as the preferred treatment for children aged 5 to 11 based on evidence showing that this combination was superior to SABA alone, particularly in reducing exacerbations. Additionally, using regular ICS did not result in more side effects or greater adrenal suppression. The recommendations are in line with current practices for treating newly diagnosed asthma in this age group. This shift in recommendations could affect current asthma management practices by reinforcing the use of ICS as a standard treatment option, ensuring more children receive effective management for their asthma symptoms, and potentially improving overall asthma control.</td>\n",
       "      <td>applies her e. The r ecommendations ar e not based on a specific e vidence sear ch, but t he \\ncommitt ee not ed that people in t he MART studies r eview ed for recommendations 1 .7.3 to \\n1.7.6 (see t ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>What are the recommended immediate steps and objective tests for diagnosing asthma in individuals who present with acute respiratory symptoms?</td>\n",
       "      <td>The recommended immediate steps and objective tests for diagnosing asthma in individuals who present with acute respiratory symptoms are as follows:\\n\\n1. Treat people immediately if they are acutely unwell or highly symptomatic at presentation.\\n2. Perform objective tests that may help support a diagnosis of asthma, such as:\\n   - Eosinophil count\\n   - Fractional exhaled nitric oxide (FeNO)\\n   - Spirometry\\n   - Peak expiratory flow (PEF) before and after bronchodilator, if the equipment is available.\\n3. If objective tests for asthma cannot be done immediately, carry them out when acute symptoms have been controlled and advise people to contact their healthcare professional if they become unwell while waiting for the tests. \\n\\nThese steps ensure timely intervention and accurate diagnosis in acute situations.</td>\n",
       "      <td>The recommended immediate steps for diagnosing asthma in individuals who present with acute respiratory symptoms are:\\n\\n1. Treat people immediately if they are acutely unwell or highly symptomatic at presentation.\\n2. Perform objective tests to support a diagnosis of asthma, which may include:\\n   - Eosinophil count\\n   - Fractional exhaled nitric oxide (FeNO)\\n   - Spirometry\\n   - Peak expiratory flow (PEF) before and after bronchodilator, if the equipment is available.\\n\\nIf objective tests cannot be done immediately, they should be carried out when acute symptoms have been controlled, and individuals should be advised to contact their healthcare professional if they become unwell while waiting for these tests.</td>\n",
       "      <td>and signs of ot her causes of r espirat ory sympt oms but be awar e that e ven if \\nexamination r esult s are normal, t he person ma y still ha ve ast hma. [NICE 2017] \\nInitial tr eatmen t and obje cti...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                            Question  \\\n",
       "0                                                                       What factors influenced the committee's decision to retain and update the step 4 treatment recommendations for hypertension, despite a lack of new evidence?   \n",
       "1                                                                                      What are the recommended strategies for monitoring asthma control during patient reviews, according to the guidelines from NICE and BTS/SIGN?   \n",
       "2                                         What steps should be taken if a child under 5 with suspected asthma continues to experience symptoms despite a trial of low-dose inhaled corticosteroids and short-acting beta-2 agonists?   \n",
       "3  What evidence led the committee to recommend low-dose inhaled corticosteroids (ICS) as the preferred treatment for children aged 5 to 11, and how might this shift in recommendations impact current asthma management practices?   \n",
       "4                                                                                     What are the recommended immediate steps and objective tests for diagnosing asthma in individuals who present with acute respiratory symptoms?   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Answer A (BGE + config A)  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  The committee's decision to retain and update the step 4 treatment recommendations for hypertension was influenced by their significant clinical experience with the safe and effective use of alpha- or beta-blockers. They agreed that adding another drug is likely to have a greater effect on blood pressure than increasing the thiazide diuretic dose, which was supported by their discussion surrounding the lack of evidence for high-dose thiazide diuretics improving cardiovascular outcomes. Additionally, they considered the need for clarity regarding the features that warrant same-day referral and the importance of quickly investigating target organ damage before treatment decisions for those with severely raised blood pressure but no other concerning symptoms.   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            The guidelines do not specify the recommended strategies for monitoring asthma control during patient reviews. Therefore, I do not know the answer to your question.   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  If a child under 5 with suspected asthma continues to experience symptoms despite a trial of low-dose inhaled corticosteroids (ICS) and short-acting beta-2 agonists (SABA), the following sequential steps should be taken:\\n\\n1. Check inhaler technique and adherence.\\n2. Check whether there is an environmental source of their symptoms (e.g., mould in the home, cold housing, smokers, or indoor air pollution).\\n3. Review whether an alternative diagnosis is likely.\\n\\nIf none of these explain the failure to respond to treatment, the child should be referred to a specialist in asthma care.   \n",
       "3  The committee recommended regular low-dose inhaled corticosteroids (ICS) plus a short-acting beta 2 agonist (SABA) as the initial treatment for children aged 5 to 11 with newly diagnosed asthma based on several studies that addressed the question of optimal therapy. This evidence indicated that low-dose ICS alongside SABA was effective for managing asthma in this age group.\\n\\nAdditionally, a single study demonstrated that maintenance and reliever therapy (MART) was superior to both regular moderate-dose ICS plus SABA as needed and regular low-dose ICS/long-acting beta agonist (LABA) plus SABA as needed. MART not only reduced the number of exacerbations and the need for a reliever inhaler but also resulted in fewer adverse events.\\n\\nThe economic analysis associated with this guideline update suggested that the MART regimen was linked to lower costs and resulted in more quality-adjusted life years (QALYs) compared to the other treatment strategies.\\n\\nThe shift in recommendations may align current management practices more closely with evidence-based approaches, ensuring that children with asthma receive more effective treatment tailored to their needs, potentially leading to better control of symptoms and fewer exacerbations.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                        The recommended immediate steps and objective tests for diagnosing asthma in individuals who present with acute respiratory symptoms are as follows:\\n\\n1. Treat people immediately if they are acutely unwell or highly symptomatic at presentation.\\n2. Perform objective tests that may help support a diagnosis of asthma, such as:\\n   - Eosinophil count\\n   - Fractional exhaled nitric oxide (FeNO)\\n   - Spirometry\\n   - Peak expiratory flow (PEF) before and after bronchodilator, if the equipment is available.\\n3. If objective tests for asthma cannot be done immediately, carry them out when acute symptoms have been controlled and advise people to contact their healthcare professional if they become unwell while waiting for the tests. \\n\\nThese steps ensure timely intervention and accurate diagnosis in acute situations.   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Answer B (OpenAI + config B)  \\\n",
       "0  The committee's decision to retain and update the step 4 treatment recommendations for hypertension was influenced by several factors:\\n\\n1. **Clinical Experience**: The committee discussed their clinical experience and deemed it important in the absence of new evidence. \\n\\n2. **Previous Recommendations**: They considered the previous recommendations from the 2011 guideline, which were based on robust clinical and cost-effectiveness evidence.\\n\\n3. **Common Clinical Practice**: The use of aldosterone antagonists has become common in clinical practice, warranting the retention of related recommendations despite the lack of robust new evidence.\\n\\n4. **Ineffectiveness of Higher Doses**: The committee noted that studies had shown no improvement in cardiovascular outcomes at higher doses of thiazide diuretics in patients without resistant hypertension, influencing their perspective on step 4 treatment.\\n\\n5. **Clinical Safety**: The committee found significant clinical experience supporting the safe and effective use of alpha- or beta-blockers, reinforcing the decision to retain related recommendations.\\n\\nOverall, the combination of established clinical practice, expert consensus, and safety considerations contributed to the decision to retain and update the recommendations for step 4 treatment.   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 The recommended strategies for monitoring asthma control during patient reviews according to the guidelines from NICE and BTS/SIGN include:\\n\\n1. Use of a validated symptom questionnaire (e.g., the Asthma Control Questionnaire, the Asthma Control Test, or the Childhood Asthma Control Test) at any asthma review.\\n2. Monitoring the amount of reliever inhaler used, including a check of the prescription record.\\n3. Keeping track of the number of courses of oral corticosteroids.\\n4. Documenting any admissions to hospital or attendance at an emergency department due to asthma.\\n5. Considering fractional exhaled nitric oxide (FeNO) monitoring for adults with asthma at their regular review. \\n\\nAdditionally, if asthma control is deemed suboptimal, the recommendations suggest referring to the principles of pharmacological treatment.   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       If a child under 5 with suspected asthma continues to experience symptoms despite a trial of low-dose inhaled corticosteroids (ICS) and short-acting beta-2 agonists (SABA), the following steps should be taken:\\n\\n1. Check inhaler technique and adherence.\\n2. Check whether there is an environmental source of their symptoms (for example, mould in the home, cold housing, smokers, or indoor air pollution).\\n3. Review whether an alternative diagnosis is likely.\\n\\nIf none of these explain the failure to respond to treatment, refer the child to a specialist in asthma care.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The committee recommended regular paediatric low-dose ICS plus SABA as the preferred treatment for children aged 5 to 11 based on evidence showing that this combination was superior to SABA alone, particularly in reducing exacerbations. Additionally, using regular ICS did not result in more side effects or greater adrenal suppression. The recommendations are in line with current practices for treating newly diagnosed asthma in this age group. This shift in recommendations could affect current asthma management practices by reinforcing the use of ICS as a standard treatment option, ensuring more children receive effective management for their asthma symptoms, and potentially improving overall asthma control.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                The recommended immediate steps for diagnosing asthma in individuals who present with acute respiratory symptoms are:\\n\\n1. Treat people immediately if they are acutely unwell or highly symptomatic at presentation.\\n2. Perform objective tests to support a diagnosis of asthma, which may include:\\n   - Eosinophil count\\n   - Fractional exhaled nitric oxide (FeNO)\\n   - Spirometry\\n   - Peak expiratory flow (PEF) before and after bronchodilator, if the equipment is available.\\n\\nIf objective tests cannot be done immediately, they should be carried out when acute symptoms have been controlled, and individuals should be advised to contact their healthcare professional if they become unwell while waiting for these tests.   \n",
       "\n",
       "                                                                                                                                                                                           Source chunk (A) preview  \n",
       "0    developed t o suppor t healt hcare professionals and people wit h hyper tension t o discuss \\ntheir tr eatment options and mak e informed decisions. \\nHow the r ecommenda tions mig ht affect practice \\nT...  \n",
       "1  specialist. [NICE 2017] \\n1.5 M onitoring asthma c ontrol \\n1.5.1 Monit or asthma contr ol at every review . In addition t o asking about sympt oms, \\ncheck: \\n• time off w ork or school due t o ast hma \\n...  \n",
       "2    childr en under 5 . \\n1.9.1 Consider an 8 t o12 w eek trial of twice-daily paediatric lo w-dose inhaled \\ncorticost eroid (ICS) as maint enance t herap y (wit h a shor t-acting beta 2 agonist \\n[SABA] f ...  \n",
       "3     applies her e. The r ecommendations ar e not based on a specific e vidence sear ch, but t he \\ncommitt ee not ed that people in t he MART studies r eview ed for recommendations 1 .7.3 to \\n1.7.6 (see t ...  \n",
       "4     and signs of ot her causes of r espirat ory sympt oms but be awar e that e ven if \\nexamination r esult s are normal, t he person ma y still ha ve ast hma. [NICE 2017] \\nInitial tr eatmen t and obje cti...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "rows = []\n",
    "\n",
    "# zip() pairs up the results from A and B so we can compare the answers to the same question\n",
    "for qa_a, qa_b in zip(results_a, results_b):\n",
    "    rows.append({\n",
    "        \"Question\": qa_a[\"question\"],\n",
    "        \"Answer A (BGE + config A)\": qa_a[\"answer\"],       # Output from the local model pipeline\n",
    "        \"Answer B (OpenAI + config B)\": qa_b[\"answer\"],    # Output from the OpenAI pipeline\n",
    "        \"Source chunk (A) preview\": qa_a[\"chunk\"][:200] + \"...\" # Snippet of the text the question was generated from\n",
    "    })\n",
    "\n",
    "# Create a DataFrame to visualize the comparison as a neat table\n",
    "df_comparison = pd.DataFrame(rows)\n",
    "display(df_comparison) # Renders the dataframe in the notebook\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d06db215",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
